Drag

Tarsons Products Limited

Healthcare TARSONS

194.10INR
-1.06 ( -0.54%)

Last update at 2026-01-30 15:53:22

Day Range

192.30196.00
LowHigh

52 Week Range

198.00 458.00
LowHigh

Fundamentals

  • Previous Close 195.16
  • Market Cap 11941.79M
  • Volume71,838
  • P/E Ratio 57.98
  • EBITDA 1104.02M
  • Revenue TTM 4020.61M
  • Revenue Per Share TTM 75.57
  • Gross Profit TTM 2614.89M
  • Diluted EPS TTM 3.87

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Total Revenue
Net Income

Balance Sheet

Total Assets
Total Liabilities

Change in Cash

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Income before tax 448.01M 607.68M 1087.20M 1349.89M 924.34M
Net income 297.70M 426.40M 807.14M 1006.64M 688.70M
Total Revenue 3924.14M 2963.94M 2832.48M 2991.90M 2279.09M
Gross Profit 1350.92M 985.42M 2181.94M 2191.26M 1536.29M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 10800.40M 9721.84M 7256.83M 5442.26M 2959.50M
Intangible assets 317.42M 366.03M 5.12M 6.64M 5.83M
Other current assets 112.69M 9.29M 118.50M 110.96M 637.73M
Deferred long term liab - - - - -
Non current assets other - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Change in Cash 85.42M -419.48M -183.84M 751.10M -229.79M
Operating Cash 966.20M 1027.05M 755.99M 834.67M 681.55M
Free Cash Flow -550.87M -816.28M -1143.69M -485.02M 38.33M

Peer Comparison

Sector: Healthcare Industry: Medical Instruments & Supplies

Company Change Price Market Cap (M) P/E Ratio
TARSONS
Tarsons Products Limited
-1.06 -0.54% 194.10 11941.79 57.98
POLYMED
Poly Medicure Limited
-116.50 -7.75% 1386.00 180105.67 49.83
AGARWALEYE
AGARWALEYE
-6.45 -1.41% 450.00 106150.05 453.72
LAXMIDENTL
LAXMIDENTL
-4.29 -2.07% 203.28 -

Profile

Tarsons Products Limited manufactures and trades in scientific plastic labware products in India and internationally. The company offers bottles and carboys; boxes and racks; cell cell culture ware, centrifuge ware, clamps and stands, cryoware, desiccator, tubings and connectors, filtration, genomics and PCR consumables, laboratory equipment and utilities, liquid handling consumables and reusables, magnetic stirrer bar, pp storage plates, sampling aids, vials and tubes, and volumetric reusables. It also provides general lab ware products. Its products are used in molecular biology, cell culture, genomics, proteomics, and immunology. Tarsons Products Limited was incorporated in 1983 and is headquartered in Kolkata, India.

Tarsons Products Limited

Martin Burn Business Park, Kolkata, India, 700091

Key Executives

Name Title Year Born
Mr. Sanjive Sehgal Chairman, CEO & MD 1961
Mr. Santosh Kumar Agarwal CFO, Company Sec. & Compliance Officer NA
Mr. Rohan Sehgal Whole-time Director 1988
Keshavmurthy Annantrao Kabboor Chief Operating Officer NA
Mr. Santosh Kumar Agarwal CFO, Company Secretary & Compliance Officer NA
Mr. Aryan Sehgal Whole-time Director 1988
Mr. Lakshmananarayanan Balakrishna Reddy Vice President of Operations NA
Mr. Subhra Sankar Bose Head of Human Resource NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data ("EODHD") on an 'as is' basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.